First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting

By sjmartinez • September 29, 2024

Nicholas SB, Correa-Rotter R, Desai NR, Guo L, Navaneethan SD, Pantalone KM, Wanner C, Hamacher S, Fatoba ST, Horvat-Broecker A, Garreta-Rufas A, Gay A, Merz M, Wheeler DC. First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Sep 28. doi: 10.1007/s40620-024-02070-y. Epub ahead of print. PMID: 39340711.

Tags: Chronic kidney disease, Finerenone, Nephrology, Non-interventional study, Publications, Type 2 diabetes

Experiences and perspectives of patients and their caregivers on gastrointestinal symptoms in peritoneal dialysis: Workshop report

Hayat A, Johnson DW, Manera K, Viecelli AK, Wilkie M, Shen J, Wang AY, Htay H, Jaure A, Cho Y, Walker R. Experiences and perspectives[...]

Associations Between Donor-derived Cell-free DNA Dynamics and Clinical Outcomes After Kidney Allograft Rejection: A Prospective, Multi-center Study

Bunnapradist S, Leca N, Zaky ZS, Stratta RJ, Khamash HA, Shihab F, Ekwenna O, Aldana-Campos M, Kahwaji J, Biancone L, Maw TT, Biagini DG, Kaur[...]

Clinical characteristics and CKD care delivery in African American and American Indian or Alaska Native patients: A real-world cohort study

Mayhand KN, Alicic RZ, Kornowske LM, Jones CR, Daratha KB, Reynolds CL, Nicholas SB, Thorpe RJ Jr, Bui AAT, Norris KC, Tuttle KR. Clinical characteristics[...]